PH18503A - Quinoline derivatives - Google Patents
Quinoline derivativesInfo
- Publication number
- PH18503A PH18503A PH27361A PH27361A PH18503A PH 18503 A PH18503 A PH 18503A PH 27361 A PH27361 A PH 27361A PH 27361 A PH27361 A PH 27361A PH 18503 A PH18503 A PH 18503A
- Authority
- PH
- Philippines
- Prior art keywords
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8117642 | 1981-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH18503A true PH18503A (en) | 1985-08-02 |
Family
ID=10522379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH27361A PH18503A (en) | 1981-06-09 | 1982-05-28 | Quinoline derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4435405A (mo) |
| EP (1) | EP0066993B1 (mo) |
| JP (1) | JPS58965A (mo) |
| AR (1) | AR230437A1 (mo) |
| AT (1) | ATE11534T1 (mo) |
| AU (1) | AU556719B2 (mo) |
| CA (1) | CA1189077A (mo) |
| CS (1) | CS238624B2 (mo) |
| DE (1) | DE3262122D1 (mo) |
| DK (1) | DK152428C (mo) |
| ES (3) | ES512960A0 (mo) |
| FI (1) | FI77451C (mo) |
| GR (1) | GR76452B (mo) |
| HU (1) | HU186523B (mo) |
| IE (1) | IE53064B1 (mo) |
| IL (1) | IL65852A (mo) |
| IN (1) | IN158970B (mo) |
| NO (1) | NO161066C (mo) |
| NZ (1) | NZ200878A (mo) |
| PH (1) | PH18503A (mo) |
| PL (1) | PL135871B1 (mo) |
| PT (1) | PT75024B (mo) |
| SU (1) | SU1192618A3 (mo) |
| YU (2) | YU43269B (mo) |
| ZA (1) | ZA823586B (mo) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3371511D1 (en) * | 1982-04-07 | 1987-06-19 | Ici Plc | Quinoline derivatives |
| DE3377796D1 (en) * | 1982-05-04 | 1988-09-29 | Ici Plc | Quinoline derivatives |
| US4585866A (en) * | 1982-06-09 | 1986-04-29 | Merrell Dow Pharmaceuticals Inc. | Treatment of migraine with substituted tropyl benzoate derivatives |
| GB8308601D0 (en) * | 1983-03-29 | 1983-05-05 | Ici Plc | Heterocyclic compounds |
| JPS60166406A (ja) * | 1984-02-09 | 1985-08-29 | 株式会社イナックス | 乾式プレス装置の坏土充填方法 |
| GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
| JP2733511B2 (ja) * | 1988-10-22 | 1998-03-30 | 日本臓器製薬株式会社 | 新規アミノアルカン誘導体 |
| JPH03147803A (ja) * | 1989-11-06 | 1991-06-24 | Tiger Mach Seisakusho:Kk | 表面多色変化模様のあるコンクリートブロックの製造方法 |
| FR2795645B1 (fr) | 1999-06-30 | 2001-09-21 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
| US6566361B2 (en) | 1999-06-30 | 2003-05-20 | Laboratories, Upsa | Azapirone pain treatment |
| WO2001023350A1 (fr) * | 1999-09-28 | 2001-04-05 | Nihon Nohyaku Co., Ltd. | Derives de thioalkylamine et methode de preparation desdits derives |
| FR2810664B1 (fr) * | 2000-06-27 | 2004-12-24 | Adir | Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
| EP2129378B1 (en) | 2007-02-28 | 2011-06-01 | Thromboserin Limited | Therapeutic compositions comprising thromboserin or a salt thereof for use in the prevention or treatment of thrombosis in a patient at risk of bleeding |
| JP2011507835A (ja) | 2007-12-21 | 2011-03-10 | アンドレイ・アレクサンドロビッチ・イワシェンコ | α−アドレナリン受容体、ドーパミン、ヒスタミン、イミダゾリン及びセロトニン受容体のリガンド並びにその使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1049379B (de) | 1959-01-29 | Farbenfabriken Bayer Aktiengesellschaft, Leverkusen-Bayerwerk | Verfahren zur Herstellung von 4 - (tert.-Aminoalkylmercapto)chinolinverbindungen | |
| DE430960C (de) | 1924-07-11 | 1926-06-23 | J G Farbenindustrie Akt Ges | Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten |
| US1572768A (en) | 1925-06-26 | 1926-02-09 | Winthrop Chem Co Inc | Pharmaceutical product |
| US1860286A (en) | 1929-05-16 | 1932-05-24 | Soc Of Chemical Ind | Basic ethers of aryl-quinolines |
| GB1511390A (en) * | 1975-12-04 | 1978-05-17 | Pfizer Ltd | Imidazolylalkyl sulphide antifungal agents |
| US4343805A (en) | 1978-12-16 | 1982-08-10 | John Wyeth & Brother Limited | Heterocyclic compounds |
-
1982
- 1982-05-19 IN IN381/DEL/82A patent/IN158970B/en unknown
- 1982-05-20 AU AU83863/82A patent/AU556719B2/en not_active Expired
- 1982-05-21 DE DE8282302607T patent/DE3262122D1/de not_active Expired
- 1982-05-21 EP EP82302607A patent/EP0066993B1/en not_active Expired
- 1982-05-21 AT AT82302607T patent/ATE11534T1/de not_active IP Right Cessation
- 1982-05-23 IL IL65852A patent/IL65852A/xx not_active IP Right Cessation
- 1982-05-24 ZA ZA823586A patent/ZA823586B/xx unknown
- 1982-05-25 IE IE1243/82A patent/IE53064B1/en not_active IP Right Cessation
- 1982-05-26 US US06/382,116 patent/US4435405A/en not_active Expired - Lifetime
- 1982-05-27 GR GR68281A patent/GR76452B/el unknown
- 1982-05-28 PH PH27361A patent/PH18503A/en unknown
- 1982-06-02 CA CA000404277A patent/CA1189077A/en not_active Expired
- 1982-06-02 FI FI821965A patent/FI77451C/fi not_active IP Right Cessation
- 1982-06-07 HU HU821828A patent/HU186523B/hu unknown
- 1982-06-08 SU SU823450275A patent/SU1192618A3/ru active
- 1982-06-08 CS CS824253A patent/CS238624B2/cs unknown
- 1982-06-08 PL PL1982236836A patent/PL135871B1/pl unknown
- 1982-06-08 NZ NZ200878A patent/NZ200878A/en unknown
- 1982-06-08 JP JP57097043A patent/JPS58965A/ja active Granted
- 1982-06-08 YU YU1232/82A patent/YU43269B/xx unknown
- 1982-06-08 NO NO821904A patent/NO161066C/no not_active IP Right Cessation
- 1982-06-08 PT PT75024A patent/PT75024B/pt unknown
- 1982-06-09 DK DK257782A patent/DK152428C/da not_active IP Right Cessation
- 1982-06-09 ES ES512960A patent/ES512960A0/es active Granted
-
1983
- 1983-01-14 ES ES519006A patent/ES519006A0/es active Granted
- 1983-08-30 AR AR294046A patent/AR230437A1/es active
- 1983-09-01 ES ES525298A patent/ES525298A0/es active Granted
-
1984
- 1984-11-08 YU YU1882/84A patent/YU42905B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2094789B (en) | Carbostyril derivatives | |
| GB8311973D0 (en) | Quinoline derivatives | |
| GB8417905D0 (en) | Hydroxymethyl-5 oxazolidinic derivatives | |
| ZA827905B (en) | Morphinane derivatives | |
| GB2111483B (en) | 3-acylamino-4-hydroxy-phenethylamine derivatives | |
| DE3262122D1 (en) | Quinoline derivatives | |
| GB8402358D0 (en) | Quinoline derivatives | |
| GB2108109B (en) | Carbostyril derivatives | |
| DE3377796D1 (en) | Quinoline derivatives | |
| GB2101986B (en) | Thiazolinoazetidinone derivatives | |
| GB2099424B (en) | Isoprenylamine derivatives | |
| GB2155932B (en) | Phenylhydrazinomethylenemalononitrile derivatives | |
| GB2099419B (en) | Imidazothizole derivatives | |
| GB2101990B (en) | Isocarbostyril derivatives | |
| GB2094297B (en) | Apovincaminol derivatives | |
| GB2098613B (en) | Polyisoprenylamine derivatives | |
| GB2099423B (en) | Isopyrenylamine derivatives | |
| GR81006B (en) | Pyrimidoiso quinoline derivatives | |
| GB2112781B (en) | Aminopropylaminobleomycin derivatives | |
| GB8301377D0 (en) | Quinoline derivatives | |
| EP0066144A3 (en) | Benzylazole derivatives | |
| GB2136799B (en) | Quinoline derivatives | |
| GB2108105B (en) | Isoprenylamine derivatives | |
| GB2106908B (en) | Alkoxyvincamone derivatives | |
| GB2100728B (en) | 3-substituted -2- cyclopentenone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Record of annual fee payments |
Year of fee payment: 11 |